UNSPSC 51101604: Meglumine antimonate

This classification denotes an antihelminthic agent with the molecular formula C7H18NO8Sb, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75G4TW236W, chemically known as hydroxy(dioxo)-?5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol but generally known as meglumine antimonate, which bears US NIH Compound Identifier 64953. European Medicines Agency schedules Meglumine Antimonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12915MIG.

World Health Organization schedules meglumine antimonate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule meglumine antimonate under HS 29221980 and SITC 51461. SMILES: CNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O.

UNSPSC 51101604 Meglumine antimonate is a Commodity code that state and local governments use to classify pharmaceutical and medical supply procurement, though recent solicitations show the code capturing a broader range of health-system purchases — naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products, and emergency medical supplies — rather than the antimonate compound alone. State and local issuing bodies pursuing contracts under this taxonomy span county health departments, state health commissions, municipal fire departments, and multi-state cooperative purchasing alliances. Seminole County, Florida and the City of Tampa both solicited medical and emergency supplies through IFB and ITB notices; Texas Health and Human Services Commission issued an RFI to explore direct-to-manufacturer pharmaceutical contracting; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP for generic pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon.

Geographic activity centers in Florida and Minnesota, with Texas and Oregon represented in the recent pipeline. The City of Tampa's March 2026 ITB for medical and first aid supplies to the Tampa Fire Department Rescue Division listed an estimated contract value of $700,000.00 and applied a Small Local Business Enterprise (SLBE) set-aside with a 5 percent bid discount not to exceed $10,000; the response deadline was March 13, 2026. Seminole County's IFB 60459723LAS, posted June 30, 2026, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023, though the posting date discrepancy suggests data quality issues in the source record. MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products closed to questions on February 18, 2026, with proposals due March 26, 2026, and required vendors to supply through three authorized wholesalers with contract effectiveness set for July 1, 2026.